The interferon inducing pathways and the hepatitis C virus

被引:0
|
作者
Eliane F Meurs
Adrien Breiman
机构
[1] Imperial College Faculty of Medicine Department of Virology London W2 1PG United Kingdom
[2] Pasteur Institute Hepacivirus Unit F-75015 Paris cedex France
关键词
Toll-like receptor; RNA helicase; Mitochondrial adapter Cardif; TBK1/IKKepsilon; Interferon induction; HCV NS3A protease;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The innate immune response is triggered by a variety of pathogens, including viruses, and requires rapid induction of typeⅠ?interferons (IFN), such as IFNβ and IFNα. IFN induction occurs when specific pathogen motifs bind to specific cellular receptors. In non-professional immune, virally-infected cells, IFN induction is essentially initiated after the binding of dsRNA structures to TLR3 receptors or to intracytosolic RNA helicases, such as RIG-Ⅰ/MDA5. This leads to the recruitment of specific adaptors, such as TRIF for TLR3 and the mitochondrial-associated IPS-1/VISA/MAVS/CARDIF adapter protein for the RNA helicases, and the ultimate recruitment of kinases, such as MAPKs, the canonical IKK complex and the TBK1/IKKε kinases, which activate the transcription factors ATF-2/ c-jun, NF-κB and IRF3, respectively. The coordinated action of these transcription factors leads to induction of IFN and of pro-inflammatory cytokines and to the establishment of the innate immune response. HCV can cleave both the adapters TRIF and IPS-1/VISA/MAVS/ CARDIF through the action of its NS3/4A protease. This provokes abrogation of the induction of the IFN and cytokine pathways and favours viral propagation and presumably HCV chronic infection.
引用
收藏
页码:2446 / 2454
页数:9
相关论文
共 50 条
  • [21] Molecular basis of interferon resistance in hepatitis C virus
    Perales, Celia
    Beach, Nathan M.
    Sheldon, Julie
    Domingo, Esteban
    CURRENT OPINION IN VIROLOGY, 2014, 8 : 38 - 44
  • [22] Interferon-Free Hepatitis C Virus Therapy
    Pawlotsky, Jean-Michel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (11): : 1 - 13
  • [23] Interferon treatment on glomerulonephritis associated with hepatitis C virus
    Matsumoto, S
    Nakajima, S
    Nakamura, K
    Etani, Y
    Hirai, H
    Shimizu, N
    Yokoyama, H
    Kobayashi, Y
    Tajiri, H
    Shima, M
    Okada, S
    PEDIATRIC NEPHROLOGY, 2000, 15 (3-4) : 271 - 273
  • [24] Effect of alpha interferon on the hepatitis C virus replicon
    Guo, JT
    Bichko, VV
    Seeger, C
    JOURNAL OF VIROLOGY, 2001, 75 (18) : 8516 - 8523
  • [25] Interferon treatment of acute hepatitis C virus infection
    David A. Bobak
    Current Infectious Disease Reports, 2002, 4 (2) : 103 - 104
  • [26] Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C
    DeMitri, MS
    Morsica, G
    Chen, CH
    Mele, L
    Baccarini, P
    Chianese, R
    Piccinini, A
    Lazzarin, A
    Pisi, E
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (03): : 255 - 261
  • [27] The full length Hepatitis C Virus (HCV) polyprotein and interactions with the interferon-beta signalling pathways in vitro
    Ghannad, Masoud Sabouri
    Zamani, Alireza
    INDIAN JOURNAL OF VIROLOGY, 2008, 19 (01): : 110 - 110
  • [28] HEPATITIS-C VIRUS MARKERS FOR MONITORING INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    SARACCO, G
    BALDI, M
    CALVO, PL
    MANZINI, P
    ABATE, M
    CHIABERGE, E
    BRUNETTO, MR
    RIZZETTO, M
    CHIEN, D
    KUO, G
    HOUGHTON, M
    BONINO, F
    HEPATOLOGY, 1991, 14 (04) : A75 - A75
  • [29] HEPATITIS-C VIRUS GENOTYPES AND RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C
    GOESER, T
    ROSSOL, S
    TOX, U
    KALLINOWSKI, B
    STREMMEL, W
    THEILMANN, L
    GASTROENTEROLOGY, 1995, 108 (04) : A1072 - A1072
  • [30] How Hepatitis C virus outmaneuvers the host interferon defense: implications for Hepatitis C therapeutics
    Huang, Y
    Larkin, J
    Jin, L
    Farmen, M
    Venable, D
    Glass, JI
    Tan, SL
    JOURNAL OF CLINICAL VIROLOGY, 2003, 28 : S46 - S47